Predicting persistent tumor after mole removal
Part of Cancer, Women’s health & pregnancy clinical trials.
This study uses ultrasound to check blood flow in the uterus after removing a complete hydatidiform mole, to predict the risk of developing persistent gestational trophoblastic neoplasia (a type of tumor). The goal is to identify patients who may need closer monitoring or earlier treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a complete hydatidiform mole (a type of abnormal pregnancy).
- You are medically stable and can undergo the mole removal procedure.
- You have no allergies or reactions to the anesthesia used for the removal.
- You are willing to have regular follow-up visits, including multiple ultrasounds and blood tests to monitor HCG levels.
- You are not pregnant with a partial mole or other type of molar pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different treatment approaches for hydatidiform mole when a CT scan shows lung nodules and the team cannot rule out spread. It may help guide the safest next steps and follow-up plan.
This study looks at giving pembrolizumab (a type of immune treatment) before a second evacuation procedure in people with persistent or returning molar pregnancy cancer. The goal is to see if this approach is safe and feasible, and whether it may help control the disease.
This trial is creating a database for women diagnosed with gestational trophoblastic neoplasia (GTN), which includes tumors that can develop after a molar pregnancy or other pregnancy-related conditions. By joining, you help researchers better understand and improve treatment for these rare tumors.
This trial tests whether using a hysteroscope (a tiny camera) to gently scrape the uterus again, instead of starting chemotherapy right away, can effectively treat a low-risk, pregnancy-related tumor that returns after a molar pregnancy. It's for Chinese women whose disease is still in an early, low-risk stage.
This study looks at people diagnosed with a hydatidiform mole (a rare pregnancy-related tumor) to understand how it progresses. It follows your health after the mole is removed and checks your hCG levels (a pregnancy hormone) to see if you develop a related condition called post-molar gestational trophoblastic neoplasia.
This study follows people who have been newly diagnosed with a hydatidiform mole (an abnormal pregnancy tissue growth). It aims to learn more about the condition using information from clinical evaluation and tissue testing, which may improve understanding and care in the future.
Hear when a new Gestational Trophoblastic Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.